Profile | GDS4284 / 228567_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 792.195 | 71 |
GSM687648 | Patient 402 control | 618.375 | 67 |
GSM687653 | Patient 403 control | 427.882 | 62 |
GSM687658 | Patient 404 control | 605.62 | 67 |
GSM687663 | Patient 411 control | 491.765 | 63 |
GSM687668 | Patient 422 control | 428.159 | 61 |
GSM687673 | Patient 424 control | 451.992 | 61 |
GSM687678 | Patient 425 control | 765.754 | 69 |
GSM687683 | Patient 427 control | 659.375 | 67 |
GSM687688 | Patient 428 control | 590.766 | 66 |
GSM687695 | Patient 441 control | 420.963 | 58 |
GSM687699 | Patient 443 control | 960.889 | 73 |
GSM687704 | Patient 444 control | 582.661 | 66 |
GSM687707 | Patient 448 control | 794.334 | 71 |
GSM687712 | Patient 449 control | 866.639 | 72 |
GSM687719 | Patient 450 control | 767.251 | 69 |
GSM687724 | Patient 451 control | 577.298 | 66 |
GSM687728 | Patient 452 control | 1043.71 | 75 |
GSM687646 | Patient 401 treated 24h | 716.822 | 68 |
GSM687649 | Patient 402 treated 24h | 562.993 | 65 |
GSM687665 | Patient 411 treated 24h | 519.54 | 64 |
GSM687651 | Patient 402 treated 4 weeks | 602.576 | 66 |
GSM687667 | Patient 411 treated 4 weeks | 652.219 | 67 |
GSM687670 | Patient 422 treated 24h | 515.149 | 63 |
GSM687671 | Patient 422 treated 4 weeks | 373.344 | 59 |
GSM687654 | Patient 403 treated 24h | 588.843 | 67 |
GSM687675 | Patient 424 treated 24h | 540.114 | 64 |
GSM687685 | Patient 427 treated 24h | 647.075 | 67 |
GSM687656 | Patient 403 treated 4 weeks | 398.259 | 61 |
GSM687677 | Patient 424 treated 4 weeks | 634.287 | 67 |
GSM687687 | Patient 427 treated 4 weeks | 572.149 | 65 |
GSM687692 | Patient 428 treated 4h | 757.148 | 70 |
GSM687716 | Patient 449 treated 4h | 663.644 | 68 |
GSM687722 | Patient 450 treated 4h | 1001.09 | 74 |
GSM687680 | Patient 425 treated 24h | 758.287 | 70 |
GSM687690 | Patient 428 treated 24h | 948.452 | 74 |
GSM687700 | Patient 443 treated 24h | 799.358 | 69 |
GSM687705 | Patient 444 treated 24h | 636.64 | 68 |
GSM687714 | Patient 449 treated 24h | 841.352 | 72 |
GSM687721 | Patient 450 treated 24h | 758.099 | 69 |
GSM687682 | Patient 425 treated 4 weeks | 756.222 | 70 |
GSM687694 | Patient 428 treated 4 weeks | 719.776 | 69 |
GSM687702 | Patient 443 treated 4 weeks | 703.464 | 68 |
GSM687718 | Patient 449 treated 4 weeks | 742.719 | 70 |
GSM687723 | Patient 450 treated 4 weeks | 749.246 | 70 |
GSM687661 | Patient 404 treated 4h | 584.783 | 66 |
GSM687710 | Patient 448 treated 4h | 596.554 | 67 |
GSM687726 | Patient 451 treated 4h | 743.176 | 69 |
GSM687730 | Patient 452 treated 4h | 1240.36 | 78 |
GSM687660 | Patient 404 treated 24h | 545.303 | 66 |
GSM687697 | Patient 441 treated 24h | 484.805 | 61 |
GSM687709 | Patient 448 treated 24h | 628.359 | 67 |
GSM687725 | Patient 451 treated 24h | 846.656 | 72 |
GSM687729 | Patient 452 treated 24h | 567.721 | 66 |
GSM687727 | Patient 451 treated 4 weeks | 534.25 | 64 |
GSM687731 | Patient 452 treated 4 weeks | 769.991 | 70 |